Company Overview of NanoDetection Technology Inc.
NanoDetection Technology Inc. designs and develops vitro diagnostic test platform system for potentially lethal pathogens, DNA and biomarkers. The company offers pathogens which include those found in healthcare settings (e.g., MRSA, UTI bacteria, etc.), the food chain (e.g., E. coli, Salmonella, and Listeria), and those used in bioterrorism (e.g., anthrax, ricin, etc.). It caters healthcare, food safety, and bioterrorism markets. NanoDetection Technology Inc. was founded in 2002 and is based in Franklin, Ohio.
301 Industrial Drive
Franklin, OH 45005
Founded in 2002
Key Executives for NanoDetection Technology Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact NanoDetection Technology Inc., please visit www.ndtbio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.